|Accuray Appoints Richard Pettingill, LFACHE to Board of Directors |
SUNNYVALE, Calif., May 17, 2012 /PRNewswire via COMTEX/ -- Accuray Incorporated
(ARAY), the premier radiation oncology company, announced today the appointment
of Richard Pettingill, LFACHE as a member of the company's Board of Directors
effective May 11, 2012.
Richard Pettingill's career as a healthcare executive spans four decades and
includes leadership positions in a variety of prominent organizations. Most
recently, Pettingill, who is a Lifetime Fellow of the American College of
Healthcare Executives (LFACHE), served as the President and Chief Executive
Officer of Allina Health System, Minnesota's and western Wisconsin's largest
healthcare organization. Under Pettingill's leadership, Allina Health System
emerged as one of the country's leading integrated care delivery organizations -
increasing revenues by more than 50 percent and growing its market share to more
than 30 percent. Additionally, under Pettingill's leadership, Allina was the
recipient of the Health Information Management System Society 2007 Davies Award
for the innovative implementation of a comprehensive electronic medical record
"Richard Pettingill is a proven healthcare leader and makes a great addition to
our Board of Directors," said Euan S. Thomson, Ph.D., president and CEO of
Accuray. "Pettingill's in-depth, long-standing knowledge of the healthcare
industry from the provider perspective will be an asset as Accuray navigates the
changing healthcare landscape."
After his tenure at Allina Health System, Pettingill served as an Advanced
Leadership Fellow at Harvard University in 2010. Prior to joining Allina Health
System, he served as the President and Chief Executive Officer, California
Division, Kaiser Foundation Health Plan and Hospitals where he oversaw the nearly
6 million-member health plan throughout California, as well as President and
Chief Executive Office of Camino Healthcare.
Pettingill currently serves on the boards of publicly traded companies Tenet
Healthcare Corporation and MAKO Surgical Corp.
"I am impressed with Accuray's innovative approach to radiation oncology and
pleased to be joining its Board of Directors," said Richard Pettingill. "I know
first-hand the difficult positions healthcare organizations face today with
ever-increasing pressure to control costs while improving patient care
experience. Accuray's CyberKnife and TomoTherapy Systems are advanced cancer
treatments that use innovative technology to improve the efficiency and
effectiveness of clinical care."
About AccurayAccuray Incorporated (ARAY), based in Sunnyvale, Calif., is the
premier radiation oncology company that develops, manufactures and sells
personalized innovative treatment solutions that set the standard of care, with
the aim of helping patients live longer, better lives. The Company's leading edge
technologies - the CyberKnife and TomoTherapy Systems - are designed to deliver
radiosurgery, stereotactic body radiation therapy, intensity modulated radiation
therapy, image guided radiation therapy, and adaptive radiation therapy. To date,
635 systems have been installed in leading hospitals around the world. For more
information, please visit accuray.com.